Acacia Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 72

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $104M

Acacia Pharma General Information

Description

Developer of pharmaceutical products designed to offer specialized medicinal products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy. The company focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures and chemotherapy.

Contact Information

Formerly Known As
Letterhood Limited
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • The Officers' Mess
  • Royston Road
  • Cambridge CB22 4QH
  • England, United Kingdom
+44 01223
Primary Industry
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • The Officers' Mess
  • Royston Road
  • Cambridge CB22 4QH
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acacia Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 09-Jun-2022 $104M Completed Generating Revenue
11. PIPE 19-Feb-2021 Completed Generating Revenue
10. PIPE 14-Aug-2020 Completed Generating Revenue
9. PIPE 02-Jan-2020 Completed Generating Revenue
8. IPO 05-Mar-2018 Completed Generating Revenue
7. Later Stage VC 21-Nov-2017 Completed Generating Revenue
6. Later Stage VC 25-Aug-2015 Completed Generating Revenue
5. Later Stage VC (Series B) 06-Jun-2014 Completed Generating Revenue
4. Later Stage VC (Series B) 03-Sep-2013 $23.5M $34.6M Completed Generating Revenue
3. Early Stage VC 01-Feb-2012 $1.11M $11.1M Completed Generating Revenue
To view Acacia Pharma’s complete valuation and funding history, request access »

Acacia Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Preferred
B Preferred
Series A 9,692,856 $0.000156 $1.2 $1.2 4x $1.2 22.82%
Series S 3,910,732 $0.000156 $1.2 $1.2 5x $1.2 9.21%
To view Acacia Pharma’s complete cap table history, request access »

Acacia Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products designed to offer specialized medicinal products to improve the care of patients un
Pharmaceuticals
Cambridge, United Kingdom
72 As of 2020

Vienna, Austria
 

Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acacia Pharma Competitors (35)

One of Acacia Pharma’s 35 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
Helsinn Healthcare Corporation Lugano, Switzerland
Ardelyx Formerly VC-backed Waltham, MA
Indivior Corporate Backed or Acquired North Chesterfield, VA
You’re viewing 5 of 35 competitors. Get the full list »

Acacia Pharma Patents

Acacia Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202108238-D0 Thearpy of post-operative nausea and vomiting Inactive 09-Jun-2021
AU-2021305446-A1 Therapy of post-operative nausea and vomiting Active 06-Jul-2020
AU-2021305446-B2 Therapy of post-operative nausea and vomiting Active 06-Jul-2020
CA-3187665-A1 Therapy of post-operative nausea and vomiting Pending 06-Jul-2020
EP-4175631-A1 Therapy of post-operative nausea and vomiting Pending 06-Jul-2020 A61K31/40
To view Acacia Pharma’s complete patent history, request access »

Acacia Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acacia Pharma Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cosmo Pharmaceuticals Corporation Minority
Eight Roads Corporate Venture Capital Minority
F-Prime Venture Capital Minority
Gilde Healthcare PE/Buyout Minority
Lundbeckfonden BioCapital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Acacia Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Acacia Pharma’s complete esg history, request access »

Acacia Pharma FAQs

  • When was Acacia Pharma founded?

    Acacia Pharma was founded in 2007.

  • Where is Acacia Pharma headquartered?

    Acacia Pharma is headquartered in Cambridge, United Kingdom.

  • What is the size of Acacia Pharma?

    Acacia Pharma has 72 total employees.

  • What industry is Acacia Pharma in?

    Acacia Pharma’s primary industry is Pharmaceuticals.

  • Is Acacia Pharma a private or public company?

    Acacia Pharma is a Private company.

  • What is the current valuation of Acacia Pharma?

    The current valuation of Acacia Pharma is .

  • What is Acacia Pharma’s current revenue?

    The current revenue for Acacia Pharma is .

  • How much funding has Acacia Pharma raised over time?

    Acacia Pharma has raised $190M.

  • Who are Acacia Pharma’s investors?

    Cosmo Pharmaceuticals, Eight Roads, F-Prime, Gilde Healthcare, and Lundbeckfonden BioCapital are 5 of 7 investors who have invested in Acacia Pharma.

  • Who are Acacia Pharma’s competitors?

    Pfizer (Vienna), Pfizer Pakistan, Helsinn Healthcare, Ardelyx, and Indivior are some of the 35 competitors of Acacia Pharma.

  • When was Acacia Pharma acquired?

    Acacia Pharma was acquired on 09-Jun-2022.

  • Who acquired Acacia Pharma?

    Acacia Pharma was acquired by Eagle Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process